Scarica l'app Stockscreener
10.46
4.29%
0.43
Dopo l'orario di chiusura:
10.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FTRE Giù?
Forum
Previsione
Precedente Chiudi:
$10.03
Aprire:
$10
Volume 24 ore:
1.06M
Relative Volume:
0.69
Capitalizzazione di mercato:
$949.77M
Reddito:
$2.98B
Utile/perdita netta:
$-300.00M
Rapporto P/E:
-3.0765
EPS:
-3.4
Flusso di cassa netto:
$225.00M
1 W Prestazione:
-7.43%
1M Prestazione:
+24.23%
6M Prestazione:
+67.90%
1 anno Prestazione:
-37.81%
Intervallo 1D:
$9.72
$10.47
Intervallo di 1 settimana:
$9.72
$11.44
Portata 52W:
$3.97
$25.28
Fortrea Holdings Inc Stock (FTRE) Company Profile
Nome
Fortrea Holdings Inc
Settore
Industria
Telefono
877-495-0816
Indirizzo
8 MOORE DRIVE, DURHAM
Confronta FTRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
10.46 | 910.72M | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | Iniziato | Truist | Hold |
| 2025-04-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-06 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-07-24 | Ripresa | Barclays | Equal Weight |
| 2024-06-06 | Iniziato | Goldman | Neutral |
| 2024-05-29 | Iniziato | TD Cowen | Hold |
| 2024-05-28 | Iniziato | Mizuho | Neutral |
| 2024-03-22 | Iniziato | Robert W. Baird | Neutral |
| 2024-03-06 | Iniziato | Deutsche Bank | Hold |
| 2024-01-05 | Iniziato | William Blair | Mkt Perform |
| 2024-01-04 | Iniziato | Jefferies | Buy |
| 2023-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-12-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-11-14 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-19 | Iniziato | Citigroup | Neutral |
| 2023-09-14 | Iniziato | Evercore ISI | In-line |
| 2023-08-16 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Iniziato | BofA Securities | Underperform |
Mostra tutto
Fortrea Holdings Inc Borsa (FTRE) Ultime notizie
Why The Narrative Around Fortrea Holdings Is Shifting Amid New Analyst and Business Updates - Yahoo Finance
How Fortrea Holdings Inc. stock performs in high volatility markets2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Is Fortrea Holdings Inc. stock a buy before product launches2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Advanced analytics toolkit walkthrough for Fortrea Holdings Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com
Is Fortrea Holdings Inc. stock a buy for dividend growthTrade Ideas & Verified Technical Trade Signals - newser.com
Will Fortrea Holdings Inc. (K67) stock extend growth story2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Can Fortrea Holdings Inc. (K67) stock sustain revenue momentumRate Hike & Safe Capital Growth Trade Ideas - newser.com
Will earnings trigger a reversal in Fortrea Holdings Inc.July 2025 Setups & AI Enhanced Trading Signals - newser.com
Multi asset correlation models including Fortrea Holdings Inc.Quarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
Is Fortrea Holdings Inc. (K67) stock a contrarian opportunityWeekly Earnings Recap & Verified Short-Term Plans - newser.com
Fortrea Reports Second Quarter 2025 Results - ADVFN
Mutual of America Capital Management LLC Has $57,000 Holdings in Fortrea Holdings Inc. $FTRE - MarketBeat
Momentum divergence signals in Fortrea Holdings Inc. chartWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
Using economic indicators to assess Fortrea Holdings Inc. potential2025 Major Catalysts & High Conviction Trade Alerts - newser.com
Fortrea Holdings Inc. (FTRE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection - TipRanks
Fortrea (FTRE) to Release Earnings on Wednesday - MarketBeat
Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery? - MSN
Fortrea Holdings Inc. (FTRE) Stock forecasts - Yahoo! Finance UK
Fortrea Holdings Inc. (FTRE) Stock Forecasts - Yahoo! Finance Canada
Fortrea’s Givinostat Study: A New Hope for Young DMD Patients - TipRanks
What drives Fortrea Holdings Inc K67 stock priceTechnical Resistance Breaks & Plan Your Exit as You Enter – Risk First - earlytimes.in
Exploring October 2025's Top Undervalued Small Caps With Insider Activity - simplywall.st
Fortrea Holdings Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy - MSN
What Fortrea Holdings (FTRE)'s Debt Tender, Legal Scrutiny Mean for Investor Confidence - simplywall.st
Fortrea (NASDAQ:FTRE) Shares Down 6.9% After Analyst Downgrade - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Reach Out - ACCESS Newswire
Fortrea Holdings, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo
Is Fortrea Holdings Inc. stock attractive for income investors2025 Support & Resistance & Verified Short-Term Plans - Fundação Cultural do Pará
Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption - TipRanks
Fortrea’s Phase 3 Study on AP301: A Potential Game-Changer for Hyperphosphatemia Treatment - TipRanks
Fortrea’s Phase 1 PET Study: A Potential Game-Changer in Diagnostic Imaging - TipRanks
Fortrea Holdings Inc Azioni (FTRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):